11:35 AM EST - Neovasc Inc. : Announced today that it has completed the first three Neovasc Reducer implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina. Neovasc Inc.
shares T.NVCN are trading up $0.01 at $0.93.
